Prehabilitation of Breast Cancer-Related Lymphedema (NCT07301580) | Clinical Trial Compass
CompletedNot Applicable
Prehabilitation of Breast Cancer-Related Lymphedema
Turkey (Türkiye)40 participantsStarted 2024-10-01
Plain-language summary
This prospective prehabilitation study aims to evaluate the effects of an individualized exercise program initiated before breast cancer surgery and continued for 12 months postoperatively. The intervention focuses on incidence of breast cancer-related lymphedema, improving functional outcomes, range of motion, pain, and patient-reported measures throughout the surgical and recovery phases. Participants receive structured, personalized exercise instructions and are monitored regularly during follow-up.
The study assesses the trajectory of extremity volume difference, early postoperative pain, the recovery pattern of shoulder range of motion and changes in functional status across the first postoperative year. Additionally, it examines the incidence of lymphedema and explores demographic and clinical determinants affecting patient outcomes. The findings are expected to provide evidence for the integration of prehabilitation into standard breast cancer care pathways.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Women aged 18 years or older
* Diagnosed with breast cancer and scheduled for surgical treatment
* Able to perform prescribed upper-extremity exercises
* Able to provide informed consent and complete follow-up assessments.
Exclusion Criteria:
* Presence of metastatic disease at baseline
* Neurological, orthopedic, or systemic conditions limiting upper-extremity mobility
* Prior breast or axillary surgery on the same side
* Planned neoadjuvant chemotherapy that would delay the initiation of the exercise program
* Inability to comply with the exercise instruction or follow-up schedule
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Incidence of Lymphedema Development
Timeframe: Baseline; 1, 3, 6, and 12 months postoperatively
2
Pain Intensity
Timeframe: Baseline; 1, 3, 6, and 12 months postoperatively
3
Quality of Life Impairment
Timeframe: Baseline; 3, 6, and 12 months postoperatively
Trial details
NCT IDNCT07301580
SponsorUniversity of Health Sciences Balikesir Hospital Eduation and Research